Belize vs Ecuador: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Belize
75.0%
in 2025
Ecuador
76.0%
in 2025
Belize rank
130th
Ecuador rank
128th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Belize
- Ecuador
How they compare
Ecuador currently reports 76.0% against 75.0% in Belize, a difference of 1.0%.
Across all 18 years both countries report, Ecuador has been ahead every year.
Belize ranks 130th and Ecuador ranks 128th of 194 countries.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 77.5% | 77.5% | Ecuador |
| 2020s | 19.0% | 75.0% | 56.0% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Belize or Ecuador?
- Ecuador, at 76.0% against 75.0% in Belize as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Belize and Ecuador?
- 1.0%, with Ecuador ahead.
- How many years of comparable data are there for Belize and Ecuador?
- 18 years are reported by both, from 2008 to 2025.
- How do Belize and Ecuador rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Belize ranks 130th and Ecuador ranks 128th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.